SHS launches sixth fund — € 220 million already in first closing
Tübingen — SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over EUR 220 million for its now sixth fund at first closing. Faster than expected, the Tübingen-based healthcare investor has thus already exceeded its target of 200 million euros at the first closing of the subscription. The sixth generation of SHS funds also targets majority and minority investments in the healthcare industry. 12–15 engagements are planned. Investors can still participate in SHS VI until the “final closing”.
As part of the placement of the sixth generation of funds, the investor base was further internationalized. More than half of the SHS VI investors have already invested in predecessor funds, and some of them have significantly increased their subscription to the new generation of funds. SHS attributes the strong demand to its unique selling proposition as a sector specialist and the successful transactions of the last fund generations.
“We would like to thank our investors for their trust,” continues Hubertus Leonhardt (photo © SHS), the SHS partner and managing director responsible for fundraising. “With our sixth generation of funds, we are once again providing access to private equity in the growing healthcare market. In addition to fund performance, our sector expertise and access to transactions are key factors for our investors. In addition, our ESG and investor relations expertise, as well as our range of co-investment opportunities, are also relevant to many of our clients. We are very pleased that with fund generation six we have been able to further internationalize our investor base and expand it to include very prestigious addresses.”
The more than 60 investors in the SHS VI Fund come from the fund of funds, insurance companies, pension funds, foundations, family offices, banks, healthcare groups, church investors and entrepreneurs. The largest investors include, for example, the European Investment Fund, the Scandinavian foundation Realdania, the Swiss Helsana HealthInvest, the Baden-Württemberg-based L‑Bank and major family offices. Furthermore, the SHS investment team itself has invested significantly.
Focus on growth financing and corporate succession
“We see in our deal flow a variety of fast-growing healthcare companies, both young and established, that are candidates for investment by the new fund. Stricter regulation and a high need for innovation and internationalization are leading to increasing capital requirements in the industry. For other companies, it is a matter of a successful handover to the next generation. Here too, as an experienced partner, we can provide companies with targeted and competent support, both with minority and majority shareholdings,” says Uwe Steinbacher, Managing Partner at SHS.
The fund focuses on corporate transactions of up to EUR 250 million. The fund can refinance the corresponding equity tranches with up to EUR 50 million from its own resources. In case of higher equity requirements, SHS increases the volumes by co-investments of investors invested in the fund or syndicates with friendly private equity houses. Expansion and innovation financing, succession situations and shareholder changes represent the focus of the investments sought. Majority and minority shareholdings are possible.
About SHS Gesellschaft für Beteiligungsmanagement mbH
“SHS, an industry investor, is a private equity firm founded in 1993 that makes investments in healthcare companies in Europe. The focus of investments is on expansion financing, shareholder changes and succession situations. “Building European Healthcare Champions” is the investment philosophy according to which SHS finances and develops portfolio companies. The Tübingen-based investor is taking both minority and majority stakes. SHS funds’ national and international investors include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team. The equity investment of the AIFM-registered company is up to EUR 50 million. Volumes beyond this can be implemented with a network of co-investors. When making investment decisions, SHS places strong emphasis on considering ESG aspects and is therefore committed to the UN PRI guidelines. SHS is currently investing from its sixth fund, launched in 2022, with a volume of more than EUR 200 million. www.shs-capital.eu